Company Filing History:
1 out of 832,912 Years Active: 2003
Introduction
Jean Pierre Kraehenbuhl is a distinguished inventor based in Rivaz, Switzerland, recognized for his significant contributions to the field of immunology and vaccine development. He has been granted a patent for his innovative work involving immunogenic polypeptides, which play a critical role in protecting against pathogenic microorganisms.
Latest Patents
Kraehenbuhl holds a notable patent titled "Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions." This patent describes a purified immunogenic polypeptide that comprises an epitope unit recognized by a protective monoclonal antibody. This antibody has high affinity and specificity for a surface polysaccharide of pathogenic microorganisms of bacterial, viral, or fungal origin. The polypeptide has been demonstrated to induce a robust immune response in vivo, providing protection in mice against challenges from virulent microorganisms.
Career Highlights
Throughout his career, Jean Pierre Kraehenbuhl has focused on developing innovative solutions to combat infectious diseases. His research has led to advancements in vaccine technologies, enhancing the effectiveness of immune responses against various pathogens. His dedication to improving public health through immunological research marks him as a prominent figure in the field.
Collaborations
Kraehenbuhl has collaborated with esteemed colleagues, including Armelle Phalipon and Philippe J Sansonetti. These collaborations have contributed to the greater scientific community, fostering advancements in understanding immune responses and developing potential therapeutic interventions.
Conclusion
Jean Pierre Kraehenbuhl’s contributions to the field of vaccine development are invaluable. His innovative approach to creating immunogenic polypeptides showcases the potential of research in combating infectious diseases. As a respected inventor with a significant patent to his name, Kraehenbuhl continues to inspire future innovations in immunology.